• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBloomberg

Bloomberg

Page 10 of 100
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
HealthHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
Panama opens audit of Chinese port operator while Trump threatens to take canal back
PoliticsPanama opens audit of Chinese port operator while Trump threatens to take canal back
By Michael McDonald, Shirley Zhao and BloombergJanuary 20, 2025
Tencent stake in Skydance-Paramount draws lawmaker scrutiny
TechTencent stake in Skydance-Paramount draws lawmaker scrutiny
By Kelcee Griffis and BloombergJanuary 16, 2025
BYD wants to win over South Korea with $21,600 electric car
TechBYD wants to win over South Korea with $21,600 electric car
By Heejin Kim and BloombergJanuary 16, 2025
China discusses sale of TikTok US to Musk as one possible option
TechChina discusses sale of TikTok US to Musk as one possible option
By BloombergJanuary 13, 2025
Uniqlo owner falls most in five months on China concerns
FinanceUniqlo owner falls most in five months on China concerns
By Kanoko Matsuyama and BloombergJanuary 9, 2025
HSBC analysts see 21% upside for Hong Kong-listed Chinese stocks
FinanceHSBC analysts see 21% upside for Hong Kong-listed Chinese stocks
By John Cheng and BloombergJanuary 9, 2025
Biden to further limit Nvidia AI chip exports in final push
TechBiden to further limit Nvidia AI chip exports in final push
By MacKenzie Hawkins, Jenny Leonard and BloombergJanuary 9, 2025
Nippon Steel says there’s no Plan B to blocked U.S. Steel deal
PoliticsNippon Steel says there’s no Plan B to blocked U.S. Steel deal
By Shoko Oda and BloombergJanuary 7, 2025
China to subsidize smartphone purchases in bid to lift spending
TechChina to subsidize smartphone purchases in bid to lift spending
By BloombergJanuary 3, 2025
South Korea cuts growth forecasts after martial law fiasco
PoliticsSouth Korea cuts growth forecasts after martial law fiasco
By Sam Kim and BloombergJanuary 1, 2025
China’s finance, property firm workforces shrink for first time
FinanceChina’s finance, property firm workforces shrink for first time
By BloombergDecember 26, 2024
Chinese EV makers hit EU wall as tariffs inflate cost of imports
TechChinese EV makers hit EU wall as tariffs inflate cost of imports
By Anthony Palazzo and BloombergDecember 23, 2024
China’s hottest stock rockets 370% on craze for collectibles
FinanceChina’s hottest stock rockets 370% on craze for collectibles
By Charlotte Yang and BloombergDecember 19, 2024
Merck snags Chinese obesity drug in nearly $2 billion deal
TechMerck snags Chinese obesity drug in nearly $2 billion deal
By Robert Langreth and BloombergDecember 18, 2024
1...
  • 8
  • 9
  • 10
  • 11
  • 12
...100
Most Popular
Success
Diary of a CEO founder says he hired someone with 'zero' work experience because she 'thanked the security guard by name' before the interviewplaceholder alt text
By Emma BurleighMay 3, 2026
Personal Finance
Current price of silver as of Monday, May 4, 2026placeholder alt text
By Joseph HostetlerMay 4, 2026
Economy
America got rich and got sad. A top economist says 2020 broke something that hasn't healedplaceholder alt text
By Nick LichtenbergMay 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.